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INTRODUCTION
Buckwheat is one of favorite foods in Asian countries. Buck-
wheat is a potent major allergic food, especially the most im-
portant causes of allergy among grains commonly consumed 
in Korea.1,2 Moreover, it is one of leading causes of anaphylaxis.3 
The consumption of buckwheat in Western countries has also 
increased recently due to its gluten-free characteristics,4 and it 
has been described as a hidden allergen in Italian cuisine, such 
as pizza and pasta.5
Labeling of allergens in food merchandise is crucial, and most 
developed countries legally require labeling of common food 
allergens. Laws for the labeling vary among countries, despite 
the recommendations by the Codex Alimentarius Commis-
sion.6 Buckwheat is a major cause of food allergy in Korea, and 
Korean Food and Drug Administration (FDA) has designated 
labeling of buckwheat in foods as mandatory (KFDA official an-
nouncement 2015-77). However, labeling does not provide de-
tailed information on the content of specific allergens, and it 
would be helpful to know the concentration of these allergenic 
molecules in food products.
Various 9-, 16-, 19-, and 24-kDa protein allergens have been 
described as the major allergens from buckwheat.7 A 19-kDa al-
lergen homologous to vicilin was more specifically recognized 
by allergic patients than by asymptomatic subjects. Specific im-
munoglobulin E (IgE) measurements against the recombinant 
19-kDa allergen had better diagnostic value than those of whole 
buckwheat extracts.8,9 The 19-kDa allergen was designated as 
Fag e 3, according to the guidelines of the International Union 
of Immunological Societies Allergen Nomenclature Subcom-
mittee.
Quantification of major allergen in extracts may be essential 
for standardization of allergen, pathogensis, and epidemiologic 
studies. Various methods have been used for the quantification 
of major allergens, such as radial immunodiffusion using poly-
clonal antibodies or 2-site enzyme-linked immunosorbent as-
say (ELISA) kit. Mass spectrometry techniques could be also 
applied to detect and quantify the allergens in foods.10
In this study, we produced monoclonal antibodies (mAbs) to 
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recombinant Fag e 3 and developed a method to quantify Fag e 
3 allergen concentrations.
 
MATERIALS AND METHODS
Allergen extracts
Buckwheat and walnut extracts were prepared as described 
previously.7 In brief, buckwheat flour was extracted with phos-
phate buffered saline for 72 hours at 4°C after defatting with 
ethyl ether. The supernatant was dialyzed against distilled wa-
ter for 48 hours after centrifugation at 50,000 g for one hour at 
4°C. Subsequently, the extract was lyophilized and stored at 
-20°C until use. The protein concentration of the reconstituted 
extract in phosphate buffered saline was determined by Brad-
ford assay (Bio-Rad, Hercules, CA, USA). Peanut extract was 
kindly provided by Dr. Kyung Eun Lee (Department of Pediat-
rics, Yonsei University College of Medicine).
mAbs to recombinant Fag e 3
Recombinant Fag e 3 was expressed in Escherichia coli and 
purified using a Ni-column from inclusion bodies, as described 
previously.8 Mouse mAbs to Fag e 3 were produced by the fu-
sion of myeloma cells (Sp 2.0-Ag 14) and spleen cells from 
BALB/c mice immunized with recombinant Fag e 3 3 times at 
2-week intervals. The hybridomas that produced antibodies 
against recombinant Fag e 3 were screened by ELISA and 
cloned by limiting dilution. mAbs from the expanded clones 
were purified with protein G (Sigma-Aldrich, St. Louis, MO, 
USA). All of the antibodies were IgG1 according to mouse mAb 
isotyping reagents (Sigma-Aldrich).
Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) and immunoblot analysis
Recombinant protein or buckwheat extract was run on a 15% 
acrylamide gel containing SDS under reducing or non-reduc-
ing conditions. The gel was stained with Coomassie blue or 
transferred to a polyvinylidine difluoride membrane (0.45 μm; 
Millipore, Bedford, MA, USA). The membrane was blocked 
overnight with 3% skim milk in Tris-buffered saline containing 
0.05% Tween 20. Subsequently, membranes were reacted with 
hybridoma culture supernatant and then incubated with 
1:1,000-diluted goat anti-mouse IgE conjugated with alkaline 
phosphatase (Sigma-Aldrich). Color was developed with 3-bro-
mo-4-chloro-5-indolyl-phosphate, and nitro blue tetrazolium 
as a substrate (Promega, Madison, WI, USA).
Biotinylation of antibody
mAbs purified with a protein G column were biotinylated 
with EZ-Link® Sulfo-NHS-LC-Biotin (Thermo Fisher Scientific, 
Waltham, MA, USA). In brief, 2 mg/mL of antibodies were in-
cubated with NHS-LC-Biotin on ice for 4 hours, and unreacted 
NHS-LC-Biotin was removed by extensive dialysis against 
phosphate buffered saline.
Measurement of Fag e 3 using a 2-site ELISA
The optimal antibody combination was established by com-
paring titration curves of recombinant Fag e 3 using the 3 differ-
ent antibodies. The combination of 3D1 (10 μg/mL) as a cap-
ture antibody and biotinylated 4H8 (1:1,000-diluted) as a detec-
tion antibody gave optimal results. Antigens were diluted in 
buffers containing 1% of various detergents (Triton X, Nonidet 
P40, or SDS) to facilitate the dissociation of Fag e 3 in the ex-
tract. Some of the each sample was heated at 100°C for 5 min-
utes after the sample was diluted in detergent buffer, and com-
pared the results with samples without heat treatment.
In brief, the capture antibody was diluted in carbonate buffer 
(pH 9.6) and was coated overnight at 4°C. Serially diluted anti-
gens (recombinant Fag e 3 or allergen extracts) were added to 
the wells and incubated for one hour at room temperature after 
blocking with 3% skim milk. This was then incubated for one 
more hour after adding the detection antibody, and incubated 
again with streptavidin-conjugated peroxidase (Sigma-Aldrich) 
for 30 minutes. Microtiter plates were washed at least 3 times 
with phosphate-buffered saline containing 0.05% Tween 20 be-
tween each step. Color was developed with 2,2´-azino-bis 
(3-ethylbenzothiazoline-6-suphonic acid) (Thermo Fisher Sci-
entific) or 3.3´, 5,5´-tetramethylbenzidine (Kirkegaard Perry 
Laboratories, Gaithersburg, MD, USA).
For comparison, the concentration of Ara h 1, a vicilin-like al-
lergen from the peanut, was also determined with the Ara h 1 
ELISA kit (Indoor Biotechnologies Inc., Charlottesville, VA, 
USA).
RESULTS
Specificity of mAbs
Reactivity of the mAbs to total buckwheat extract containing 
native allergens was examined by immunoblotting with mAbs, 
which were produced against recombinant protein. In the ex-
tract, Fag e 3 separated under reducing conditions was barely 
recognized by mAbs, despite mAbs showing good reactivity to 
the extract on ELISA (Fig. 1). This observation motivated us to 
perform the immunoblot again, while separating the extract 
under non-reducing conditions. Interestingly, all of the mAbs 
preferentially recognized a 38-kDa protein, putative dimerized 
Fag e 3. We also evaluated whether the mAbs could detect vi-
cilin family major allergens of peanut (Ara h 1) and walnut (Jug 
r 2). Putative Ara h 1 (64 kDa) and Jug r 2 (44 kDa) under non-
reducing condition only were also recognized by the all mAbs, 
respectively (Fig. 2).
Sensitivity of 2-site ELISA
ELISA with selected antibodies was able to detect less than 1 
μg/mL of recombinant Fag e 3 (Fig. 3). However, it could not 
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detect native Fag e 3 in the total extract of buckwheat. There-
fore, we added various detergents to facilitate the dissociation 
of Fag e 3 in the total extract (Fig. 4). An ELISA with SDS showed 
better detection, but had lowered overall detection capability. 
The 2-site ELISA system developed in this study was able to de-
tect up to 6 μg/mL of the vicilin allergen when tested with re-
combinant Fag e 3. More than 100 μg/mL of total buckwheat 
protein is needed for efficient detection of Fag e 3 (Fig. 5).
However, the sensitivity of ELISA was improved by heating the 
antigen mixture at 100°C for 5 minutes after the addition of 1% 
Fig. 1. SDS-PAGE analysis of recombinant Fag e 3 (5 μg) and antibody responses to buckwheat extract. Recombinant protein was separated onto a 15% polyacryl-
amide gel under reducing and non-reducing conditions (A). We examined reactivity of mAbs produced against recombinant Fag e 3 to buckwheat extract by ELISA 
using hybridoma culture supernatants (B). SDS-PAGE, sodium dodecyl sulphate polyacrylamide gel electrophoresis; mAbs, monoclonal antibodies; ELISA, enzyme-
linked immunosorbent assay.
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Fig. 2. Recognition of native vicilin-like allergens by mAbs. We probed Fag e 3 and its homologous allergens with mAbs from extracts (10 μg) that were transferred 
onto a PVDF membrane after running on 15% gels that were run under reducing (A) and non-reducing (B) conditions. mAbs used to detect Fag e 3 are denoted be-
neath each membrane. M, molecular mass standard; B, buckwheat extract; P, peanut extract; W, walnut extract; mAbs, monoclonal antibodies; PVDF, polyvinylidene 
difluoride.
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SDS. The detection limit of the 2-site ELISA was 0.8 μg/mL of 
recombinant Fag e 3 (Fig. 6). The detection limit of total buck-
wheat extract was also lowered to 60 μg/mL by heating the 
samples with the detergent. Vicilin-like allergens were not de-
tected from peanut and walnut total extracts by the developed 
2-site ELISA.
Measurement of Fag e 3 in the allergen extracts
We estimate that 120 μg of Fag e 3 was found in 1 mg of total 
buckwheat extract. Fag e 3 was not also detected by the Ara h 1 
ELISA kit (Indoor Biotechnologies Inc.), although 143.75 μg of 
Ara h 1 was detected from 1 mg of peanut extract. 
DISCUSSION
Immunoassays for the quantification of allergens in food are 
useful for allergen avoidance and standardization of allergen 
extracts.11 We have developed a 2-site ELISA to quantify the 
buckwheat allergen Fag e 3 using mAbs raised against recombi-
nant Fag e 3.
All mAbs showed good reactivity to total buckwheat extract. 
However, they were not able to readily detect native Fag e 3 in 
the extract under reducing condition. All the mAbs produced 
against recombinant Fag e 3 seem to recognize the conforma-
tional epitopes of vicilin-like allergens. Ara h 1 (64 kDa) and Jug 
r 2 (44 kDa) were also recognized by the mAbs under non-re-
ducing condition.
Interestingly, individual mAbs showed good response to the 
extract in ELISA experiment, suggesting good affinity to native 
Fag e 3. However, native Fag e 3 in the extract was not detected 
by the combination of 2 mAbs, although recombinant Fag e 3 
was well quantified. mAbs to recombinant Fag e 3 may recog-
Fig. 3. Dose-dependent curve of recombinant Fag e 3 by a 2-site ELISA. The 
2-site ELISA was quantified with 4-fold dilution of recombinant Fag e 3 from 25 
μg/mL. The detection limit was 0.1 μg/mL. ELISA, enzyme-linked immunosor-
bent assay.
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Fig. 4. Application of detergents in total buckwheat extract to facilitate native 
Fag e 3 quantification. One percent detergent was added to the extract (A) and 
to recombinant Fag e 3.
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Fig. 5. Quantification of native Fag e 3 in total buckwheat extract. Addition of SDS decreased the sensitivity to recombinant Fag e 3 (A), but increased the sensitivity 
to native Fag e 3 in total buckwheat extract (B). The detection limit for recombinant Fag e 3 was 6 μg/mL (A). We created a dose-dependent curve of with 4-fold dilu-
tion of buckwheat extract from 1 mg/mL (B). SDS, sodium dodecyl sulphate.
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nize epitopes very close to each other. Binding of one mAb to 
an epitope region may decrease the accessibility of another 
mAb to a close epitope, possibly due to steric hindrance. Partial 
denaturation of Fag e 3 by detergents may increase the accessi-
bility of another mAb. Epitope mapping should be performed 
to explain this hypothesis. In addition, the binding of mAbs to 
Fag e 3 may be hampered by other proteins which associated 
with vicilins or by interactions between vicilin molecules, as 
they are known to form multimers. Typically, vicilins are disk-
shaped trimeric proteins with various subunit compositions 
due to post-translational proteolytic processing and glycosyl-
ation.12 Glycosylation may also influence antibody recogni-
tion.13 IgE reactivity to native Jug r 2 without clinical significance 
was described due to cross-reactive carbohydrate epitopes.14 
Structural similarity of vicilin-like proteins from peanut (Ara h 
1), walnut (Jug r 1), hazelnut (Cor a 11), and cashew nut (Ana o 
1) was described, indicating its potential cross-reactivity,15 and 
all mAbs produced by our team also have affinity to Ara h 1 and 
Jug r 1 under non-reducing condition.
Recombinant Fag e 3 had good IgE reactivity, indicating that it 
closely resembles its native counterpart.8 We did not observe 
structural differences in recombinant Fag e 3 based on reduc-
ing and non-reducing gels. However, reducing conditions may 
cause native Fag e 3 to undergo a slight change in its configura-
tion, as it showed different reactivity to mAbs under those con-
ditions. However, the structurally change under reducing con-
ditions is believed to retain most of its IgE epitopes, as it dis-
played good IgE reactivity based on IgE immunoblot analysis.7 
Thermal treatment (30-50 minutes) in the presence of polysac-
charides can cause structural change to vicilin-like allergens. 
This leads to markedly reduced immunogenicity through the 
Maillard reaction. However Fag t 3, a vicilin-like allergen from 
tartary buckwheat (Fagopyrum tataricum), was stable even af-
ter incubation at 90°C for 30 minutes.16 Therefore, we suspect 
that the Maillard reaction did not occur in this study during 
heat treatment with 1% SDS for 5 minutes at 100°C.
We used the detergent SDS to improve the detection of Fag e 3 
in the dilution buffer. Approximately 12% of buckwheat protein 
was found to be vicilin. Detecting allergenic components from 
food that is mixed with various seasonings, additives, and other 
foods can be challenging. In the case of the peanut, improved 
detection of Ara h 1 by 2-site ELISA were obtained by heating 
the sample and adding nonfat dry milk to the extraction buffer 
(up to 400-fold).17 Therefore, heating the antigens and using de-
tergent prior to serial dilution could improve the extraction and 
detection of buckwheat major allergen from various foods and 
environments. The sensitivity of our 2-site ELISA improved ap-
proximately 7.5 times by heating before serially diluting the an-
tigens.
Ara h 1 is a well-characterized vicilin allergen. It is a heat sta-
ble protein with a stable trimeric form (64 kDa) that is mediat-
ed through hydrophobic interactions. This protein comprises 
12%-16% of the total protein in peanut extracts.18-20 Ara h 1 was 
measured not only in peanut and food extracts, but also in vari-
ous environments.17,20,21 Buckwheat could be sensitized by in-
halation in occupational and domestic exposure, mainly due to 
buckwheat chaff-stuffed pillows contaminated with buckwheat 
flour,22 or buckwheat flour in buckwheat noodle factory.23 It is 
likely that Fag e 3 can be measured in various environmental 
dusts such as restaurants that serve buckwheat, factories that 
produce buckwheat noodles, in addition to meals that contain 
buckwheat.
The mAbs produced against recombinant Fag e 3 also recog-
nize vicilin-like allergens from tree nuts. Vicilin-like allergens 
are also described in black walnut (Jug n 2), lentil (Len c 1), pea 
(Pis s 1), cashew (Ana o 1), hazel (Cor a 1), and sesame (Ses i 3). 
Clinically relevant cross-reactivity between the pea and the 
peanut was reported due to vicilin-homologous allergens, Pis s 
1, and Ara h 1.24 However, there is a low rate of clinical cross-re-
activity among these vicilin belonged allergens.
Buckwheat 2-site ELISA kits are already produced by Crystal 
Chem Inc. (Downers Grove, IL, USA) and ELISA systems 
(Windsor, Queensland, Australia). These kits utilize buckwheat 
extract for the surveillance of buckwheat allergen contamina-
tion in foods. The food industry and official food control agency 
laboratories in Japan employ the ALLERGENEYE ELISA kit 
(Justia Legal Resources, Tokyo, Japan), which detects a 24-kDa 
allergen (a putative Fag e 1), and the FASTKIT ELISA (COSMO 
Bio Co., Ltd., Tokyo, Japan) (Notification No. 1106001, 2002).25 A 
buckwheat DNA detection system (Shimadzu Cor., Kyoto, Ja-
pan) is also available. Employing better detection systems for 
buckwheat allergens to complement the current food allergy la-
beling system is an important goal. The detection of clinically 
relevant allergens such as Fag e 2 or Fag e 3 shows better diag-
nostic value than that of the total extract.8,26 Furthermore, the 
importance of prevention of food allergy is being emphasized 
in a public health problem.27
Fig. 6. Heating after adding SDS to the buckwheat. Heating improves the sen-
sitivity of the 2-site ELISA. The detection limit was 0.8 μg/mL of recombinant 
Fag e 3. SDS, sodium dodecyl sulphate; ELISA, enzyme-linked immunosorbent 
assay.
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We hope that the Fag e 3 ELISA developed in this study is 
helpful for the standardization of buckwheat extract as well as 
the detection of buckwheat allergens in foods and environ-
ments.
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